Log in to save to my catalogue

Pulmonary arterial hypertension: the case for a bioelectronic treatment

Pulmonary arterial hypertension: the case for a bioelectronic treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f84b994c8ed54a44afc7ff97a96c00a4

Pulmonary arterial hypertension: the case for a bioelectronic treatment

About this item

Full title

Pulmonary arterial hypertension: the case for a bioelectronic treatment

Publisher

England: Springer

Journal title

Bioelectronic Medicine, 2019-12, Vol.5 (1), p.20-20, Article 20

Language

English

Formats

Publication information

Publisher

England: Springer

More information

Scope and Contents

Contents

Pulmonary arterial hypertension (PAH) is a rare disease of unknown etiology that progresses to right ventricular failure. It has a complex pathophysiology, which involves an imbalance between vasoconstrictive and vasodilative processes in the pulmonary circulation, pulmonary vasoconstriction, vascular and right ventricular remodeling, systemic infl...

Alternative Titles

Full title

Pulmonary arterial hypertension: the case for a bioelectronic treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f84b994c8ed54a44afc7ff97a96c00a4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f84b994c8ed54a44afc7ff97a96c00a4

Other Identifiers

ISSN

2332-8886

E-ISSN

2332-8886

DOI

10.1186/s42234-019-0036-9

How to access this item